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It has been acknowledged for decades that ultraviolet B (UVB) 1 (290-320 nm) 
radiation may have adverse effects on normal cutaneous processes. Acutely, UVB 
exposure  produces  cutaneous erythema and  edema  (sunburn);  chronically, it 
leads to premature cutaneous aging and to the induction of skin cancer. Recently, 
UVB radiation has been recognized to alter normal immunologic processes (1). 
Kripke et al. (2) showed that large doses of UVB delivered chronically to mice 
will not only induce cutaneous neoplasms but will also create a receptive immu- 
nologic milieu in which grafts of  such UVB-induced neoplasms will grow. Analysis 
of the immunologic defects that follow high dose UVB exposure has revealed 
two features that may be relevant: the generation of suppressor T  lymphocytes 
(3,  4)  and  the  failure  of  Ia  positive  spleen  cells  to  present  antigens  to  T 
lymphocytes (5-7).  Extrapolation of these findings from mice to man has been 
difficult because the large UVB doses employed, 180 kJ/m  ~, are as much as 400 
times the minimal phototoxic UVB dose (MPD) in untanned Caucasian skin. By 
contrast,  Toews  et  al.  (8)  have  shown  that  local  in  vivo administration of a 
relatively low UVB dose (0.2 kJ/m  ~, corresponding to  1 human MPD daily) for 
four consecutive days also produced an altered immune response in C57BL/6 
mice. When the contact-sensitizing agent DNFB was applied to the UVB-irradi- 
ated sites (but not to unirradiated sites) antigen-specific unresponsiveness rather 
than sensitization ensued. The mechanism(s) by which low doses of UVB radia- 
tion  produce  this  unresponsiveness to  contact  sensitizers  is  unknown.  In  this 
study we  show  that  the  same  dose  of UVB  radiation  that  produces  a  local 
alteration in antigen-presenting function of skin also permits suppressor T  cells 
to emerge when hapten is placed on the irradiated site. We propose that these 
suppressor T  cells are responsible at least in part for the hapten-specific unre- 
sponsive state. 
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Materials  and  Methods 
Animals.  Female C3H  mice were obtained  from Jackson  Laboratories (Bar  Harbor, 
ME),  Cumberland  View Farms  (Clinton,  TN),  or Charles  River  Breeding  Laboratories 
(Wilmington, MA). They were used for experiments when between 2 and 4 mo of age. 
Reagents.  2, 4  dinitro-l-fluorobenzene  (DNFB) and 4-ethoxymethylene-2-phenyloxa- 
zol-5-one  (oxazolone)  were  purchased  from  Sigma  Chemical  Co.  (St.  Louis,  MO).  5- 
fluorodeoxyuridine (FUdR), I12~-iododeoxyuridine (IUdR), and monoclonal anti-Thy-1.2 
antibody were obtained from New England Nuclear (Boston, MA). Arsanilate-conjugated 
monoclonal anti-Lyt-1 and anti-Lyt-2 antibodies, and rabbit anti-arsanilate antibody were 
obtained from Becton-Dickinson (Sunnyvale,  CA).  Low toxicity rabbit complement was 
purchased  from Cedarlane  Laboratories  (Hornby, Ontario).  Monoclonal anti-arsanilate 
antibody  was a  gift  of Dr. J.  Donald  Capra  (Dept.  Microbiology,  U.T.H.S.C.,  Dallas, 
Texas). 
Assessme~t of Cow,tact ttypersensitivih,.  Induction and elicitation of contact hypersensitiv- 
ity was performed according to the method of Phanuphak et al.  (9).  Briefly, mice were 
immunized  to  hapten  by  the  epicutaneous  application  of 25  #1  of 0.5%  DNFB  in  an 
acetone/olive oil (4:I) solution to the razor-shaved abdominal wall skin on days 0 and  1. 
Reactions were elicited  on day  5  by challenging one ear of each  mouse with  20 ~1  of 
0.2% DNFB. The increment in ear swelling was used as a measure of the development of 
contact hypersensitivity. Ear thickness was measured with an engineer's micrometer 1, 2, 
and 3 d (days 6, 7, and 8) after challenge and compared to the ear thickness just before 
the challenge. 
The induction and elicitation of contact hypersensitivity to oxazolone was accomplished 
in the same manner as with  DNFB with the exception that mice were sensitized with  50 
#I  of 5%  oxazolone  (in  4:1  acetone/olive  oil)  and  ear  challenged  with  20  #1  of  1% 
oxazolone solution. 
Induction of UmespoTlsiveness to Hapten.  Mice were made unresponsive to DNFB using 
the  method  of Toews et  al.  (8).  Following sedation  with  chloral  hydrate,  animals were 
restrained  in the supine position on a wooden platter.  The razor-shaved abdominal skin 
was exposed to UV radiation from a bank of four FS-20 fluorescent lamps with a tube to 
target distance of 46 cm. These bulbs have an emission spectrum primarily in the UVB 
range (10). Irradiance ranged from 0.11 to 0.14 mW/cm 2 as measured by an IL700 UVB 
research  radiometer  with an SEE 240  UVB photodetector.  Mice were exposed to UVB 
daily for 4 consecutive days (days -3 to 0).  Immediately following the final exposure and 
24 h later (days 0 and  1) 25 $1 of 0.5% DNFB was placed within the irradiated site. 
In  some  experiments,  mice  were  made  unresponsive  to  DNFB  by  the  intravenous 
inoculation of 750 mg/kg body weight of dinitrofluorobenzene sulfate (DNBS) (9). 
Adoptive Tm~sfer of Um'espoJ~siveness.  Mice were sacrificed 7 d after either the epicuta- 
neous application of DNFB on UVB irradiated skin or the intravenous administration  of 
DNBS.  Spleens and  lymph  nodes (axillary,  brachial,  inguinal,  cervical, and mesenteric) 
were  removed  and  single  cell  suspensions  prepared  fi'om  (a)  lymph  nodes  by  gentle 
squeezing through a wire mesh screen and (b) from spleen by mincing with forceps. One 
hundred million viable cells (50% lymph node, 50% spleen) were then inoculated into the 
tail vein of naive syngeneic recipients that had received 240R x-irradiation from a cesium 
source (gamma  cell  40,  Atomic  Energy of Canada,  Ltd.)  2-4  h  earlier  (11).  Recipient 
mice were then  painted  with an  immunizing dose of DNFB on the abdomen on days 0 
and  1, ear challenged on day 5, and measured for ear swelling on days 6, 7, and 8. The 
percent suppression was calculated according to the formula: 
% suppression 
=  ear swelling (positive control) -  ear swelling (experimental)  x  100%. 
ear swelling (positive control) -  ear swelling (negative control) 
Co-tra~Tsfer of lmmu~e  Cells a~d  Um'esponsive Cells.  Immune  lymph  node  cells  were 
obtained from donors immunized by the epicutaneous application of 0.5%  DNFB (25 #1 
to central body wall, 5 tA to each forepaw) on days -4 and -3. On day 0, the mice were ELMETS  ET  AL.  783 
sacrificed and cell suspensions were prepared from their peripheral lymph nodes (cervical, 
axillary, brachial, and femoral). Thirty million immune peripheral lymph node cells were 
then inoculated intravenously along with  100 x  106 spleen and lymph node ceils from 
UVB irradiated and hapten skin-painted (unresponsive) mice into naive syngeneic recipi- 
ents who had received 240R x-irradiation. Recipient mice were ear challenged 1 h after 
adoptive transfer. The increment in ear swelling was measured over the succeeding 3 d. 
Antibody Treatment of Cell Suspensio~s.  In certain experiments, spleen and lymph node 
cell  suspensions  were  depleted  of T  lymphocytes by pretreatment  with  antibody and 
complement  before  injection  into  recipient  mice.  Spleen  and  lymph  node  ceils  at  a 
concentration of 5  ×  107 cells/ml (in  RPMI  1640  [Gibco Laboratories, Grand  Island, 
NY]  containing  2%  fetal  calf serum)  were  incubated  with  monoclonal  anti-Thy-l.2 
antibody (1  #l/ml)  at  4°C  for  30  min.  The  cell  suspensions  were  then  washed  and 
incubated at a concentration of 1 x  107 cells/ml with a 1  : 10 dilution of rabbit complement 
at 37°C for 45 min. Treatment of the cell suspensions in this manner completely abrogated 
their proliferation response to Con A, but had no effect on their response to LPS (data 
not shown). 
Depletion  of Lyt-l+  and/or  Lyt-2+  lymphocytes was  accomplished by  incubating 
identical members of cells (107/ml) with either arsanilate-conjugated anti-Lyt-1 or anti- 
Lyt-2 monoclonal antibody  (8.3  #l/ml)  for  1  h  at  4°C.  A  third  aliquot  of cells  was 
incubated with normal mouse serum under similar conditions. After washing the suspen- 
sions once, cells were resuspended in  RPMI-FCS at  10V/ml  and incubated with rabbit 
anti-arsanilate antibody (11 #g/ml) for 1 h at 4°C. The cells were again washed, and then 
incubated at 2 x  107/ml for 1 h at 37°C with a  1:10 dilution of rabbit complement. 
Incorporation oflUDR Into Regional Lymph Nodes.  Panels of mice were skin painted with 
an immunizing dose of DNFB on days 0 and 1. On day 4, each mouse received 5 x  10  -8 
moles of FUdR intraperitoneally followed 10 minutes later by 2 #Ci of ~2'~I-labeled IUdR. 
Draining inguinal, axillary, and brachial lymph nodes were taken 2 h later. After three 
24-h washings  in 70% alcohol, IUdR incorporation in the nodes was measured using a 
gamma spectrometer (t 2). 
Results 
Effect of UVB Radiation  on b~duction of Contact Hypersensitivity in C3H Mice.  We 
have previously reported that local, acute, low dose UVB irradiation of abdom- 
inal wall skin of C57BL/6  mice alters the immune capabilities of these animals 
such that specific unresponsiveness, rather than sensitization, is produced (8). A 
similar  set  of experiments  was  conducted  in  C3H  mice.  Panels  of mice  were 
exposed to 0.7  kJ/m z daily for four consecutive days, skin painted with DNFB, 
and then challenged 4 d later. As the data in Table I reveal, UVB-treated animals 
had  only minimal  ear  swelling responses.  14  d  after  initial  skin  painting  with 
hapten, the dorsal body wall skin of these animals was painted with an immunizing 
dose of DNFB, which was repeated 24 h later. Appropriate positive and negative 
control panels were included. When the ears of these mice were challenged with 
DNFB  4  d  later  (19  d  after  first  application  of DNFB),  the  panel  originally 
treated with UVB failed to respond. This result indicates that C3H mice resemble 
C57BL/6 mice in their susceptibility to the effects of UVB on the induction of 
contact hypersensitivity. Epicutaneous application of hapten to UVB-treated skin 
produces a state of profound unresponsiveness. 
Adoptive  Transfer  of Unresponsiveness  by  Spleen  and  Lymph  Node  Cells.  Both 
suppressor  cell  and  nonsuppressor  cell  mechanisms  have  been  identified  as 
possible  means  by which  unresponsiveness  to contact-sensitizing agents can  be 
produced and maintained (13).  In order to determine whether suppressor cells 
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TABLE  I 
Un responsiveness to DNFB Follows Low Dose ~.q,'B and Hapten Skin Painting 
in C3H Mice 
Increment in ear 
UV  DNFB im-  swelling (X 10 -4  Suppression 
Group  radiation  munization  inches _  SEM) 
1  -  +  22.5 _+ 2.2 
II  +  +  12.2 +_ 1.I 
III  -  -  9.4  +  1.2 
% 
79 
The shaved abdominal skin of C3H mice was exposed to 700 J/m s ultraviolet 
radiation daily for 4 consecutive days. Immediately after the last exposure and 
24 h later 25 ul of 0.5% DNFB was applied epicutaneously to the irradiated site. 
5 d after the initial application of hapten mice were ear challenged with 20/4 of 
0.2% DNFB. The mean change in ear thickness was measured over the ensuing 
72 h. Increment in ear swelling represents peak response recorded. 
TABLE  II 
Un responsiveness  That Follows Low Dose UVB and Hapten Skin Painting Can Be 
Adoptively Transferred 
DNFB sen- Increment in ear  Tolerization proce-  Cells trans- 
Group  dure of donor mice  ferred  sitiza-  swelling (x 10 -4  Suppression 
tion  inches _+ SEM) 
% 
1  None  +  36.1  -4- 3.6 
II  UVB + DNFB  +  +  16.6 + 4.6  70 
III  IV DNBS  +  +  18.4 + 0.7  64 
IV  None  -  8.4 + 2.7 
Recipient naive syngeneic mice received 100 X 10  ~ spleen and lymph node cells from 
donor mice made unresponsive by low dose UV and hapten skin painting (group II) or 
by prior i.v. injection of DNBS (group Ill). Recipient mice were then immunized by 
two daily applications of 25 ~.1 of 0.5% DNFB and ear challenged 4 d later with 20 ~.1 
of 0.2%  DNFB. Comparison was made to positive controls who received no cells but 
were  sensitized and  ear challenged (group  I) and  negative controls who  were  ear 
challenged only (group IV). Responses were measured as described in Table I. 
adoptive  transfer  experiments  were  undertaken.  6  d  after  the  second  skin 
painting  of  irradiated  abdominal  skin,  donor  mice  were  sacrificed  and  cell 
suspensions prepared  from their spleens and lymph nodes. One hundred  million 
of  these  spleen  and  lymph  node  cells  were  injected  intravenously  (i.v.)  into 
normal  syngeneic  recipients,  which  were  then  skin  painted  with  DNFB  and 
challenged 4  d  later. The  increment  in ear swelling for this experimental  group 
was compared  with that of (a) mice that received no cells but were skin painted 
and  ear  challenged  (positive  controls),  (b)  mice  that  were  ear  challenged  only 
(negative controls), and (c) mice that received cells from donors made unrespon- 
sive to DNFB  by the prior (i.v.) injections of DNBS.  Table  II shows the results 
of a  representative experiment.  Mice that received spleen and lymph node cells 
from donors  made  unresponsive to DNFB  by in vivo low dose UVB and  DNFB 
skin painting were 70% suppressed compared  with positive controls. This amount 
of suppression  was  similar to  that  observed  in  recipients of cells from  donors ELMETS  ET  AL.  785 
made unresponsive by the i.v. injections of DNBS. Furthermore, panels of mice 
that received cells either from untreated donors or from donors exposed to UVB 
but not skin painted,  responded in a  manner identical to positive controls (data 
not shown). From these experiments, we conclude that the unresponsiveness to 
DNFB produced by low dose in vivo UV can be adoptively transferred, indicating 
that suppressor cells are generated by this regimen. 
Action  Spectrum for  the  Generation  of Suppressor  Cells.  The  FS-20 fluorescent 
sunlamps used in these studies have an emission spectrum primarily in the UVB 
range;  however, these  bulbs also emit a  significant  amount  of UVA radiation 
(10).  To determine  whether radiation  in  the  UVB range was required  for the 
production of suppressor cells, a window glass filter was interposed between the 
fluorescent tubes and the mice during  UV exposure. Donor mice were exposed 
to UV from the light  source with  the filter in  place and  were compared with 
donors exposed to unfiltered  UV. This glass filter removed >97% of radiation 
in the UVB range and 33% of radiation within the UVA range. To compensate 
for diminished UVA exposure, times for mice irradiated through the filter were 
increased 33% to deliver UVA dose equivalent to that administered without the 
filter. With the exception of this increased irradiation time, the adoptive transfer 
protocol was identical to that described above. As shown in Table III, panels of 
mice that  received cells from donors painted with  DNFB on irradiated  skin  in 
which the UVB radiation had been removed by the window glass filter developed 
normal  contact hypersensitivity responses.  By contrast,  mice that  received cells 
from  donors  who were  irradiated  with  unfiltered  UV were again  suppressed. 
Thus,  wavelengths of UV radiation  required  for the generation  of suppressor 
cells lie within the UVB range. 
Phenot~pic Analysis  of Suppressor  Cells.  Because macrophages (14),  B lympho- 
cytes (15,  16), and T  lymphocytes (11, 17) have all been implicated as suppressor 
cells in contact hypersensitivity, we next examined the cell type responsible for 
the  suppression  observed  when  DNFB is  applied  to  low dose  UVB-irradiated 
skin sites. Donor mice were made unresponsive to DNFB by the typical in vivo 
low dose UVB and hapten skin-painting protocol. They were sacrificed 7 d later 
and spleen and lymph node cell suspensions were prepared.  Aliquots of this cell 
TABLE  III 
Ultraviolet Radiation in the UVB Range is Required  for the Generation of 
Suppressor Cells 
Increment in  DNFB 
Group  Treatment of donors of cell  immu-  ear swelling (×  Suppres- 
suspensions  nization  10  -4 inches _  sion 
SEM) 
% 
I  +  26.4 ___ 7.2 
II  Filtered UV +  DNFB  +  28.1  --+ 3.3  None 
Ill  Unfiltered UV +  DNFB  +  11.7 +  2.8  85 
IV  -  9.2 -+ 1.7 
Recipient mice received cells from donors exposed to  UV  radiation filtered by 
window glass (group I1) or to UV radiation without the filter (group III). Groups 
I and IV received no cells. Responses were measured as described for Table I. 786  ULTRAVIOLET  B  INDUCES  SUPPRESSOR  T  CELLS 
suspension were then treated either with anti-Thy-1.2 monoclonal antibody and 
complement  or  with  the  irrelevant  monoclonal  anti-arsanilate  antibody  and 
complement as a control. Groups of mice were injected i.v. with either of these 
treated cell suspensions immediately before epicutaneous application of DNFB. 
4 d later, these mice as well as unsensitized controls were challenged with DNFB. 
As demonstrated in Table  IV,  treatment of cell suspensions with anti-Thy-l.2 
plus complement abrogated the adoptive transfer of suppression, whereas treat- 
ment with anti-arsanilate plus complement had no effect. Thus,  the  cells that 
mediate adoptive  transfer of the  suppression  produced by low-dose  UVB and 
DNFB skin painting are T  lymphocytes. 
Subpopulations of suppressor T  lymphocytes may express the Lyt-l+ pheno- 
type, the  Lyt-2+ phenotype, or both (18).  In an attempt to determine the Lyt 
phenotype of the T  iymphocytes that  mediate suppression  following low dose 
UVB irradiation and DNFB skin painting, depletion experiments with anti-Lyt- 
1  and  anti-Lyt-2  monoclonal  antibodies  were  performed.  Before  spleen  and 
lymph node cell suspensions obtained from low dose, UV-treated, DNFB-painted 
donor mice were inoculated into naive recipients, the cells were pretreated with 
either  an  arsanilate-conjugated  anti-Lyt-1  or  anti-Lyt-2  monoclonal  antibody, 
followed by rabbit anti-arsanilate antibody and then with rabbit complement. As 
demonstrated in Table V, sequential treatment with normal mouse serum, anti- 
arsanilate  antibody  and  complement  had  no  effect  on  the  unresponsiveness 
observed.  Alternatively,  recipients  of cell  suspensions  treated  with  anti-Lyt-I 
antibody plus complement responded in a manner identical to positive controls, 
i.e., this pretreatment totally eliminated suppressor cell activity. Anti-Lyt-2 plus 
complement  pretreatment  resulted  in  partial  reversal  of the  unresponsiveness 
(67%  of the suppression seen in the normal serum-treated control suspension). 
In a parallel experiment in which similar conditions for cell lysis were employed, 
pretreatment  of cells  obtained  from  5-d  mixed  lymphocyte reactions  of C3H 
spleen cells vs C57BL/6 x-irradiated spleen cells with anti-Lyt-1 plus complement 
had no effect on their capacity to lyse 5~Cr-labeled EL4 target cells in a standard 
4-h  cytotoxicity assay.  By  contrast,  specific  cytotoxicity of similar  aliquots  of 
TABLE  IV 
Suppressor Cells Ge~ler(lted by Low Dose UVB and Hapten Skin Painting Are 
T Lymphoo,tes 
Increment in  DNFB  ear swelling  (x  Suppres-  Treatment of cell  immu-  10  -4 inches _+  sion  Group  suspension  nization 
SEM) 
% 
I  +  34.5 -+ 5.2 
II  Anti-Thy,  conlplement  +  39.3 + 5.1  --22 
Ill  Anti-Ars,  complement  +  17.0 + 3.6  79 
IV  -  12.4 -+ 1.9 
Cell suspensions from unresponsive donor mice were treated in vitro with anti- 
Thy-l.2 and complement (group II) or with anti-arsanilate and complement 
(group lII). The cells remaining following  treatment were then injected i.v. into 
recipient mice. Groups I and IV received no cells. Responses were measured as 
described in Table I. ELMETS  ET  AL. 
TABLE  V 
Ly-Phe~otype of Suppressor Cells Ge~erated by Low Dose UVB 
Radiatio~ a~d DNFB Skb~ Painting 
Treatment of do-  DNFB  Increment in ear 
Group  nor cell suspen-  immuni-  swelling (×  10  -4  Suppres- 
sion  sion  zation  inches _+ SEM) 
% 
I  +  24.2 _+ 3.9 
II  Anti-Lyt-1  +  21.9 _  4.1  l0 
III  Anti-Lyt-2  +  12.8  +  1.0  48 
IV  NMS  +  6.9 +  1.4  72 
V  -  0.3 _+  1.6 
Cell suspensions from unresponsive donors were treated with either arsan- 
ilate-conjugated Lyt-1 +  antibody, arsanilate conjugated Lyt-2+ antibody 
or normal mouse serum (NMS).  Each  cell suspension was then treated 
with rabbit anti-arsanilate antibody and complement. The cells remaining 
after antibody and complement treatment were injected into naive recip- 
ients which were then immunized and ear challenged with DNFB. Groups 
I and V received no cells.  Responses were measured as described in Table 
1. 
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cultured cells was only partially reduced (from 30% seen in controls to  16%) by 
pretreatment with anti-Lyt-2 plus complement. This result strongly implies that 
the lysis of Lyt-2+ cells under the experimental conditions employed was incom- 
plete. We therefore conclude that T  cells bearing the Lyt-1 marker are crucial 
for suppression  to occur. We more tentatively conclude that  Lyt-2+ cells also 
participate in this suppression.  Whether the suppression is mediated through a 
single population  of Lyl+23+ cells or through distinct  T  cell subsets, one of 
which the Lyl+23- and the other of which is Lyl÷23+ and Lyl-23+, cannot 
be determined from the studies performed to date. 
Antige~ Spec~cit~, of Suppressor Cells.  Suppressor cells in intact hypersensitivity 
reactions may act specifically against cells reactive to  the antigen that induces 
them, or they may act nonspecifically. We chose next to examine the specifcity 
of the  suppressor  cells  generated  following  low  dose  UVB  and  hapten  skin 
painting. Donor mice were made unresponsive to DNFB, sacrificed, and suspen- 
sions of spleen and lymph node cells prepared according to the typical protocol. 
These cells were injected into two panels of naive recipient mice. One panel was 
then skin painted and ear challenged with DNFB; the other was skin painted and 
challenged with oxazolone, a non-cross-reacting contact-sensitizing agent. Recip- 
ient mice that  received cells from DNFB  unresponsive donors and were then 
sensitized and challenged with DNFB showed suppressed ear-swelling responses. 
By contrast, mice that received cells from DNFB unresponsive donors and were 
then skin painted and ear challenged with oxazolone developed normal contact 
hypersensitivity responses (Table VI). This result indicates that the suppressor 
cells generated by low dose UVB and hapten skin painting are specific for the 
antigen that elicited them. 
A~al~,sis  of Locus  of Actio~  of Suppressor  Cells,  Suppressor  cells  in  contact 
hypersensitivity that act within the afferent limb of the response to inhibit the 
generation of effector cells (19), and others that operate within the efferent limb 788  ULTRAVIOLET  B  INDUCES  SUPPRESSOR  T  CELLS 
TABLE  VI 
Suppressor Cells Generated by Low Dose UVB and Hapten Skin Painting are 
Antigen  Specific 
Recipients  Hapten used  Hapten used  % of positive  Suppression 
of DNFB  for immuniza-  for ear chal-  control 
Group  unrespon-  tion  lenge 
sive cells 
I  -  DNFB  DNFB  100 
II  +  DNFB  DNFB  35 
III  -  --  DNFB  16 
IV  -  Ox  Ox  100 
V  +  Ox  Ox  92 
VI  -  --  Ox  31 
% 
77 
12 
Cell suspensions from donor mice made unresponsive to DNFB were injected into two 
groups of recipient  mice.  Group  II  was  immunized and ear challenged with  DNFB. 
Group  V  was  immunized and  ear  challenged  with  oxazolone  (Ox).  Responses were 
measured as the percent of the appropriate positive control. 
to impair  the  function  of effector cells (20),  have been  described.  In  order to 
determine whether the suppressor cells generated by low dose UVB and DNFB 
skin painting  could effect efferent suppression,  a  co-transfer of immune  lymph 
node cells with  unresponsive spleen and  lymph node cells into naive recipients 
was performed. In this experiment, one panel of donor mice was immunized to 
DNFB by applying the hapten  to abdominal skin and forepaws on days -4  and 
-3.  Another panel of donor mice was made unresponsive to DNFB by the low 
dose UVB and hapten  skin-painting protocol beginning on day -10. On day 0, 
both panels of donor mice were sacrificed. Cell suspensions were prepared from 
the peripheral  lymph nodes of the immune donors; spleen and lymph node cell 
suspensions were prepared from the unresponsive donors. In preliminary exper- 
iments,  it was determined  (a) that  30  x  106 peripheral  lymph node cells from 
immune donors consistently could transfer contact hypersensitivity reactions to 
naive recipients and (b) that efferent suppression could be demonstrated by co- 
transferring  30 x  106  immune cells with  100  x  106 suppressor cells generated 
by the epicutaneous application of supraoptimal doses of DNFB (data not shown). 
In this experiment, 30 ×  106 immune cells were inoculated with 100 x  106 UVB- 
induced suppressor cells into naive recipients that were ear challenged  1 h after 
cell  transfer.  This  response  was  compared  with  panels  of mice  that  received 
immune  cells only, and  to negative  controls.  As can  be seen  in Table  VII,  no 
suppression was observed in the panel that received immune cells and suppressor 
cells. Therefore,  the  suppressor  cells generated  by low dose  UVB and  DNFB 
skin painting do not appear to act on the efferent limb of the contact hypersen- 
sitivity response. 
These results suggest that the suppressor cells might act on the afferent limb 
of the  contact hypersensitivity response.  We examined  next the ability of sup- 
pressor  cells  to  inhibit  the  proliferation  of cells  in  draining  lymph  nodes  of 
recipient  mice painted with  DNFB. Though  proliferating  cells in  lymph nodes 
draining  skin  painted  with  hal~ten  may  not  be  the  actual  effector  cells,  the 
incorporation  of IUdR by draining  lymph  nodes has  been  shown  to correlate ELMETS  ET  AL. 
TABLE  VII 
Suppressor Cells Fail to Inhibit Ear Swelling After Co-transfer of 
Immune Lymph Node Cells 
Increment in 
Group  Ceils transferred  ear swelling 
(x 10  -4 in _+ SEM) 
I  Immune  27.9 _+ 3.3 
II  Unresponsive + Immune  26.9 + 3.8 
III  None  13.7 + 5.9 
Cell suspensions from unresponsive donors were transferred  with (group 
II) or without (group I) immune lymph node cells. Recipient mice were 
ear challenged one hour after cell transfer.  Responses were measured as 
described in Table I. 
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TABLE  VIII 
Suppressor Cells Inhibit In Vivo DNA Synthesis in Draining Lymph 
Nodes 
DNFB  IUdR 
Group  Type of cell suspension  immuni-  incorpora-  Suppres- 
received  sion  zation  tion 
%  % 
I  Naive cells  +  0.2 
II  DNFB unresponsive  +  0.1  59 
III  None  -  0.03 
Cell suspensions from unresponsive donors (group II) or from naive donors 
(group I) were injected into naive recipient mice who were then immunized 
to DNFB. 3 d after immunization each mouse was given 2 t~Ci IUdR i.p. 
The mice were sacrificed 2 h later and the 1% incorporation of IUdR into 
draining lymph nodes was measured. 
with  the  induction  of contact  hypersensitivity  (19).  In  this  experiment,  naive 
recipients  of spleen  and  lymph  node  cells  from  donors  made  unresponsive  to 
DNFB  by low  dose  UVB  and  hapten  skin  painting  were  skin  painted  with  an 
immunizing  dose  of DNFB.  3  d  later  each  mouse  received an  intraperitoneal 
injection of FUdR followed by an intraperitoneal injection of II2~-labeled IUdR. 
Mice  were  then  sacrificed  and  the  percent  IUdR  incorporated  into  draining 
lymph nodes  was  measured.  As demonstrated  in  Table  VIII, incorporation  of 
IUdR into draining lymph nodes of mice that received spleen and  lymph node 
cells from mice made unresponsive to  DNFB was significantly suppressed com- 
pared with animals that received cells from naive syngeneic donors. We conclude 
that the suppressor cells generated  by low dose  UVB and  DNFB skin painting 
act  on  the  afferent  limb  of  the  immune  response,  and  thereby  inhibit  the 
induction  of effector cells for contact hypersensitivity. 
Discussion 
Local irradiation  of murine skin with doses of UVB radiation that are compa- 
rable  to  typical  human  exposure  to  sunlight  profoundly  alters  the  capacity of 
that skin  to  serve as a  medium  for the  induction  of contact  hypersensitivity to 790  ULTRAVIOLET  B  INDUCES  SUPPRESSOR  T  CELLS 
simple haptens. Epicutaneous application of haptens such as DNFB and oxazolone 
to body wall skin normally produces a state of intense contact hypersensitivity. 
By contrast,  similar doses of DNFB  applied  to  UVB-irradiated skin  produces 
profound, specific unresponsiveness. As we demonstrated previously in Syrian 
hamsters,  hapten-specific unresponsiveness  induced in  this  manner in  mice is 
infectious (21). Adoptive transfer of the unresponsive state is achieved by Thy- 
1+ suppressor cells that act on the afferent limb of the immune response, but 
fail  to  suppress  immune effector cells.  Our  results  indicate  that  suppression 
requires a cell population that is Lyt-1 +, and further suggest the participation of 
cells bearing the Lyt-2+ marker. More definitive characterization of the respon- 
sible  suppressor  T  cells will  require analysis of such factors as their idiotypic 
orientation and the genetic restrictions on  transferring suppression (including 
analysis of the role of I-J). While antibodies capable of identifying a DNP-specific 
idiotypic  network  are  unavailable  to  us  at  present,  experiments  employing 
monoclonal anti-I-J antibodies are currently in progress. 
During the past several years a large number of laboratories using a variety of 
model systems have studied regulatory phenomena in specific immune suppres- 
sion (18,  22,  23). A  number of related but apparently nonidentical suppressor 
regulatory pathways that involve interactions among cells with different pheno- 
types have been described. Recently, Germain and Benacerraf (24) raised the 
question whether the described pathways could represent fragments of larger 
single sequence; they then developed a model system that attempted to integrate 
the data from several of the more extensively defined suppressor systems into a 
"consensus" suppressor pathway. In this model three distinct suppressor T  cells 
and their secretory factors sequentially conspire to regulate both humoral and 
cell-mediated immune reactions. 
An  incompletely developed suppressor  network,  in  which  only  first  order 
suppressor T  cells (T~l or Tsan~), which can only inhibit the afferent limb of an 
immune response, are detectable, appears to be a frequent result when soluble 
hapten or hapten-derivatized lymphoid cells are introduced intravenously on a 
single occasion. Thus a  single i.v.  injection of DNBS  results within 7  d  in  the 
appearance of afferent, but not efferent T  suppressor cells (reference 23,  see 
also Tables II, VII, and VIII).  In the "consensus" system, in order for efferent 
suppressor  cells  (Tsz  and  T~3) to  be  activated,  antigen  re-exposure is  usually 
necessary.  In  the  model  described  in  this  report,  hapten  applied  to  UVB- 
irradiated skin results in the appearance of suppressor cells that act only on the 
afferent limb of the contact hypersensitivity response. This model superficially 
mimics that induced by intravenous introduction of DNBS.  However, the sup- 
pressor  cells  in  the  two  systems apparently  have  distinctive  Lyt  phenotypes: 
suppression  in  our  UVB radiation  model was eliminated by removing Lyt-l+ 
cells from the suspension; in the i.v.  DNBS system, afferent suppressors are not 
removed by anti-Lyt-l, but are eliminated by anti-Lyt-2 (_]. Moorhead, personal 
communication). 
The  suppressor  cells generated in  the present  UVB-hapten  model are also 
apparently different from those generated in another model that also involves 
introduction of reactive hapten (DNFB) to the animal via epicutaneous applica- 
tion. The suppressor T  cells generated in mice after epicutaneous application of ELMETS ET  AL.  791 
supraoptimal  amounts  of DNFB  can  suppress both  the  afferent  and  efferent 
limbs of the  response  in  adoptive recipients (23),  whereas  the present  model 
generates only afferent limb suppressor activity. Thus, the suppressor network 
activated by hapten application to UVB-irradiated skin is both incomplete and 
also apparently distinct from other related models. This realization implies that 
the  type  of  antigen  processing  and  presentation  via  the  skin  that  leads  to 
unresponsiveness may also be relatively unique. 
The line of investigation that this series of experiments advances concerns the 
role of epidermal Langerhans cells in the induction of contact hypersensitivity. 
At least two types of epidermal ceils--Langerhans cells and keratinocytes--may 
participate in cutaneous immune processes. Langerhans cells are bone marrow- 
derived cells (25, 26) that bear C3b and Fc surface membrane receptors (27) and 
express large amounts of Ia determinants (28,  29,  30).  They appear  to act as 
epidermal  antigen-presenting  cells  and  are  capable  of stimulating  allogeneic 
lymphocytes in  mixed epidermal cell-lymphocyte reactions (31).  Keratinocytes 
may  participate  by  elaborating  the  soluble  mediator,  epidermal  cell-derived 
thymocyte activating factor (ETAF), a substance with immunobiologic properties 
that are similar to interleukin-1  (32,  33).  Since the doses of UVB used in these 
experiments cause massive morphologic alterations in exposed Langerhans cells, 
it is tempting to conclude that the unresponsiveness to haptens results from the 
failure of these Langerhans cells to present epicutaneous haptens effectively to 
T  cells.  However, this circumstantial argument can not exclude the possibility 
that keratinocytes play an important role in the UVB radiation effects observed 
in the present  studies.  It  has been  reported  recently that  ETAF  will partially 
reconstitute the UVB-induced loss of stimulatory capacity of epidermal cells in 
the  mixed  epidermal  cell  lymphocyte  reaction  (34).  The  potential  tolerance 
(suppression)-promoting effect of diminished ETAF  production at  the  site  of 
UVB radiation and hapten application has not been examined. The fact that a 
tolerogenic signal emerges from the skin that has been UVB radiated and painted 
with hapten raises the possibility that the source of the signal may be keratinocytes 
and/or products derived therefrom. We have recently demonstrated that hapten- 
derivatized keratinocytes largely depleted of Langerhans cells produce profound 
unresponsiveness when inoculated intravenously into Syrian hamsters. This effect 
is overcome when significant numbers of viable, haptenated Langerhans cells are 
included in the inoculum (35). 
Chronic and/or  high-dose UVB radiation of the type described and studied 
by Fisher et al. (4) and Spellman et al. (3) and their respective associates results 
in the induction of systemic unresponsiveness, mediated by suppressor T  cells. 
However,  these  suppressor  cells  differ  substantially  from  the  cell(s)  we  have 
identified after acute,  low dose  UVB exposure.  Induction of the latter cells is 
completely dependent upon epicutaneous application of hapten to the radiated 
sites (8).  There  is no generic,  systemic impairment in  immune responsiveness 
since mice irradiated only on abdominal skin can be sensitized to hapten readily 
if it is painted on dorsal body wall skin. Moreover, mice receiving local, low dose, 
UVB radiation are  fully capable of developing typical delayed hypersensitivity 
when  immunized subcutaneously with  hapten-derivatized  syngeneic lymphoid 
cells (36).  These findings indicate that locally irradiated mice have no systemic 792  ULTRAVIOLET B INDUCES SUPPRESSOR T  CELLS 
impairment  in  antigen-presenting cells--a  characteristic feature  of mice  that 
have received chronic and/or large exposures to UVB radiation. Our evidence 
suggests  that  local,  acute,  low  dose  UVB  radiation  causes  a  perturbation  of 
cutaneous immune capabilities that is distinct from that induced by chronic, high 
dose UVB radiation. 
The adverse effects of actinic radiation on normal cutaneous processes can be 
interpreted in terms of the experimental results we have described in this report. 
Exposure of skin to UVB causes a transient impairment in the capacity of that 
skin to present epicutaneous antigens in an immunogenic form. Antigens intro- 
duced at that critical time are perceived as tolerogens, and an antigen-specific 
systemic network of suppression is established. If for purposes of discussion, the 
offending antigen happens to be an opportunistic virus or a  neoantigen on a 
malignant epidermal cell, synchronous exposure to antigen and UVB radiation 
may evoke unresponsiveness and rob  the  host of the precise  armamentarium 
needed to ward off the attack. 
Summary 
Acute, low dose ultraviolet B radiation of murine body wall skin followed by 
local application of DNFB produces a state of antigen-specific unresponsiveness. 
This  state  is  maintained  at  least  in  part  by  an  Lyt-l+  T  cell  that  effects 
unresponsiveness by impairing the induction phase of contact hypersensitivity. 
The absence of suppressor cells capable of  acting at the effector stage of  immunity 
suggests  that  tolerogenic  signals  derived  from  the  skin  establish  suppressor 
networks  that  are  incomplete  and  perhaps  different from  networks  that  are 
induced by systemic administration of tolerogens. It is proposed that ultraviolet 
radiation produces its effects by impairing the antigen-presenting potential of 
resident Langerhans cells in whose absence hapten-derivatized keratinocytes (or 
their products) are able to deliver a tolerogenic signal. 
Received for publication  28 March 1983 and in revised form 7June 1983. 
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